483 Merck Sharp & Dohme Apr 2011

483 Merck Sharp & Dohme Apr 2011

Helen Ricalde FDA$119.00 - Available Now

FDA investigators audited the Merck Sharp & Dohme - West Point, PA, United States facility and issued inspectional observations (via FDA 483) on 27 Apr 2011.

Product details

  • Category: Biologics
  • Inspection end: 27 Apr 2011
  • Location: West Point, United States
  • FEI: 2510592
Add To Cart